BEVERLY, Mass., Aug. 18, 2016 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the Credit Suisse 7th Annual US Small & Mid Cap Conference. The conference is scheduled for September 14th in New York City.
Axcelis management will host one-on-one meetings with interested investors during the conference. For more information on the conference or to schedule a one-on-one meeting, please contact a Credit Suisse representative or the conference coordinator at: [email protected]
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 35 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552
SOURCE Axcelis Technologies, Inc.